Houston biotech firm raises additional funds to close $43M Series D

The new funding aids the biotech firm on its path toward FDA approval, the CEO told the Houston Business Journal.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 12, 2019 Category: Pharmaceuticals Authors: Chris Mathews Source Type: news